Previous Close | 86 |
1-Year Change | 76.88% |
6-Months Change | -3.26% |
3-Months Change | -25.2% |
Moving Avg (50d) | 90.563 |
Moving Avg (200d) | 94.773 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 5.22B |
Beta (3-Years) | 1.27 |
Revenue Growth (ttm) | -20.59% |
Net Profit Margin (ttm) | -256.57% |
Return On Assets (ttm) | -50.19% |
EPS (ttm) | -9.19 |
PE Ratio (ttm) | -9.36 |
Dividend Yield | % |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |